4. Xia Jiang, Kunjie Wang, Mingming Ding, Jiehua Li, Hong Tan, Zhigao Wang & Qiang Fu. Quantitative grafting of peptide onto the nontoxic biodegradable waterborne polyurethanes to fabricate peptide modified scaffold for soft tissue engineering. Journal of Materials Science: Materials in Medicine 2011; 22(4):819-827. (IF 1.955)
5. Luo Yang, Xiang Li, Kun Jie Wang(通訊作者). Perirenal Hematoma Became Bilateral Ureteropelvic Junction Obstruction After One Month Later: a Case Report. Healthmed 2011；5（3)：596-8.
6. Zhang P, Shi M, Wei Q,, Wang K, Li X, Li H, Bu H. Increased expression of connective tissue growth factor in patients with urethral stricture. Tohoku J Exp Med. 2008 Jul;215(3):199-206.
7. JIN Tao, LI Hong, JIANG Li-hai, WANG Li, WANG Kun-jie(通訊作者). Safety and efficacy of laser and cold knife urethrotomy for urethral stricture. Chinese Medical Journal 2010;123(12) :1589-1595.
8. Peng Wu, Li Wang, Kunjie Wang(通訊作者). Supine versus prone position in percutaneous nephrolithotomy for kidney calculi: a meta-analysis. International Urology and Nephrology 2011;43:67-77.
9. Preeti Chhabra, Kunjie Wang, Qiang Zeng， et al. Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection. Cell Transplant. 2010;19(5):597-612.
10. Chen Y, Li H, Dong Q, Wang KJ. Blockade of alpha(1A)-adrenoceptor: A novel possible strategy for male contraception. MEDICAL HYPOTHESES. 2009; 73(2): 140-141.
11. Zhang P, Wei Q, Li X, Wang KJ, Zeng H, Bu H, Li H. A FUNCTIONAL INSERTION/DELETION POLYMORPHISM IN THE PROMOTER REGION OF NFKB1 GENE INCREASES SUSCEPTIBILITY FOR PROSTATE CANCER. J Urol. 2009; 181(4):11. (Meeting Abstract)
12. Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H, Li H. A functional insertion/deletion polymorphism in the
gydjdsj.org.cn promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet. 2009;191(2):73-7.
13. Kunjie Wang, Nan Zhang, Hong Li. Improved technique of mouse heterotopic heart graft retransplantation. Microsurgery, 2006, 15(2): 200-202.
14. K. Wang, H. Zhang, Y. Li, et al. Efficacy of Mycophenolate Mofetil Versus Azathioprine After RenalTransplantation: A Systematic Review. Transplantation Proceedings, 2004, 36（7), 2071–2072.
15. K. Wang, H. Zhang, Y. Li, et al. Safety of Mycophenolate Mofetil Versus Azathioprine in Renal Transplantation: A Systematic Review. Transplantation Proceedings, 2004, 36（7), 2068–2070.
16. Wang K, Li Y, Li X, Jiang H, Shen J, Zhang L. Pig orthotopic renal allotransplantation model. Transplant Proc. 2003 Feb;35(1):191.
17. Zhang H, Li Y, Li S, Wang K, Cheng J. The status of chimeric cells in human-to-pig spleen transplantation. Transplant Proc. 2003 Feb; 35(1):533-4.
18. LI Y, Wang K, Cheng J, et al. Huamn-pig spleen transplantation leading to high level of chimerism. Transplant Pro, 2000, 32（5):1103-4
19. 王坤杰，張海濤，李幼平，盧一平，魏強，李虹， 楊宇如. 腎移植術(shù)后運用驍悉與
硫唑嘌呤的安全性評價. 中國循證醫(yī)學雜志，2005；5(5)：365-374. 統(tǒng)計源期刊
20. 王坤杰， 李虹，魏強
gydjdsj.org.cn，等. 成人Wilms瘤診斷和治療.
中國腫瘤臨床 2003； 30（6)：454-455. Medline收錄
21. 楊宇如，王坤杰.器官移植免疫耐受的評價.當代醫(yī)學.2001；7（11)：34-38.
22. 張海濤，王坤杰，李幼平，高勵，劉瑾，蔡羽嘉. 腎移植術(shù)后驍悉與硫唑嘌呤抗排斥反應(yīng)隨機對照試驗的系統(tǒng)評價. 中國循證醫(yī)學雜志，2004；4(2)：79-91. 統(tǒng)計源期刊
23. 李幼平，王坤杰.引入循證醫(yī)學，提高腹部外科醫(yī)療水平. 腹部外科 2001;14(6):324-327.
24. 張海濤， 李幼平， 王坤杰，李勝富，程驚秋. 人→
豬脾塊移植嵌合細胞的體內(nèi)轉(zhuǎn)歸. 四川大學學報 2003；34（1)∶20-23. Medline收錄
25. 黃翔; 申吉泓; 李虹; 王坤杰; 魏大鵬; 楊宇如. 尿道瘢痕成纖維細胞培養(yǎng)及藥物對其生長的影響. 華西醫(yī)科大學學報 2002; 33(2):220-222.
26. 辛宇鵬; 盧一平; 高銳; 張秀輝; 李幼平; 吳大蓉; 王坤杰. 益生注射液延緩大鼠慢性移植腎腎病的進程. 中華器官移植雜志 2003; 26(3):171-174.
27. 石明; 曾定冬; 魏強; 李虹; 王坤杰. 鈣化為主的腎錯構(gòu)瘤誤診為
腎結(jié)石1例. 臨床泌尿外科雜志 2002; 17(9): 480.
28. Wang Kunjie. Expression of NOS in bladder transitional cell carcinoma. China Medical Abstracts中國醫(yī)學文摘.外科學分冊(英文版) 2003; 12(2): 114-115.
29. 熊瑋，王坤杰， 王莉， 王佳，魏強，李虹. 坦索羅辛用于
輸尿管結(jié)石排石治療隨即對照試驗的Meta分析. 中國循證醫(yī)學雜志 2007；7（7)：506-515.
上一頁 [1] [2] [3] [4] 下一頁
